Brainstorm Cell Therapeutics reported 0.03 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Biogen 13.7 0.32 Mar/2026
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Cipla 23.56 4.18 Mar/2026
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 4.06 75.75 Dec/2025
CSL 16.16 9.59 Dec/2025
Gilead Sciences 17.7 2.07 Mar/2026
Grifols 11.2 1.08 Dec/2025
Halozyme Therapeutics 11.35 11.8 Mar/2026